這幾個(gè)問(wèn)題讓你3分鐘了解雅思是什么?今天小編給大家?guī)?lái)這幾個(gè)問(wèn)題讓你3分鐘了解雅思是什么，希望能夠幫助到大家，下面小編就和大家分享，來(lái)欣賞一下吧。
這幾個(gè)問(wèn)題讓你3分鐘了解雅思是什么
雅思考試(國(guó)際英語(yǔ)語(yǔ)言測(cè)試系統(tǒng))是聽(tīng)說(shuō)讀寫(xiě)四項(xiàng)英語(yǔ)交流能力的測(cè)試。
每年，全球有超過(guò)270萬(wàn)人次在140個(gè)國(guó)家和地區(qū)參加雅思考試。雅思已成為全球英語(yǔ)測(cè)評(píng)領(lǐng)導(dǎo)者。
全球超過(guò)10,000所院校機(jī)構(gòu)所認(rèn)可。無(wú)論你想留學(xué)、移民、就業(yè)，還是檢測(cè)英語(yǔ)水平;無(wú)論你想去英國(guó)、美國(guó)、加拿大、澳大利亞、新西蘭，還是荷蘭法國(guó)、德國(guó)、新加坡、香港等;你只需要一項(xiàng)英語(yǔ)考試—雅思考試。
雅思考試分類及作用講解
1.雅思考試
考試用途及分類
雅思考試是為那些打算在以英語(yǔ)作為交流語(yǔ)言的國(guó)家和地區(qū)留學(xué)或就業(yè)的人們?cè)O(shè)置的英語(yǔ)言水平考試。
學(xué)術(shù)類：適用于出國(guó)留學(xué)申請(qǐng)本科，研究生及以上學(xué)位，或獲得專業(yè)資質(zhì)
培訓(xùn)類：英語(yǔ)國(guó)家移民申請(qǐng)(如澳大利亞，加拿大，新西蘭及英國(guó))或申請(qǐng)培訓(xùn)及非文憑類課程
考試結(jié)構(gòu)
學(xué)術(shù)類：聽(tīng)力：30分鐘+10分鐘 學(xué)術(shù)類閱讀：60分鐘 學(xué)術(shù)類寫(xiě)作：60分鐘 口語(yǔ)：11-14分鐘
培訓(xùn)類：聽(tīng)力：30分鐘+10分鐘 培訓(xùn)類閱讀：60分鐘 培訓(xùn)類寫(xiě)作：60分鐘 口語(yǔ)：11-14分鐘
考試形式
紙筆考試或機(jī)考+人人對(duì)話
兩種模式的聽(tīng)力和口語(yǔ)一樣，閱讀文章不同但題型相似，寫(xiě)作的第一題不同，第二道題風(fēng)格一致但內(nèi)容不同。
聽(tīng)力
聽(tīng)力始終是雅思整個(gè)考試的第一部分，一般為獨(dú)白或兩人、多人對(duì)話，共有4個(gè)單元，40道題，考40分鐘。普通培訓(xùn)類和學(xué)術(shù)類聽(tīng)力部分的題目完全一樣。4個(gè)單元的難度是依次遞增的。前兩單元主要是一些日常生活中有關(guān)的各種場(chǎng)景，例如購(gòu)物、就餐等方面的談話。后兩個(gè)單元?jiǎng)t是學(xué)生在學(xué)習(xí)過(guò)程中遇到的一些典型場(chǎng)景，如對(duì)教育、學(xué)術(shù)以及世界性話題的探討。
聽(tīng)力部分常見(jiàn)的題型包括選擇題、簡(jiǎn)答題、填空題、圖表題、配對(duì)題。(16-5.0;23-6.0;30-7.0)
閱讀
雅思考試中普通培訓(xùn)類和學(xué)術(shù)類閱讀部分的試卷完全不同。
普通培訓(xùn)類的文章基本來(lái)自廣告、報(bào)紙、說(shuō)明書(shū)、時(shí)間表、雜志等一些實(shí)用性很強(qiáng)的文字載體，考題主要是對(duì)考生的總體理解能力、定位文中細(xì)節(jié)能力和對(duì)比文中細(xì)節(jié)能力等進(jìn)行考核。題型多樣，有配對(duì)題、簡(jiǎn)答題、完成句子、選擇段落標(biāo)題、圖表題等。
學(xué)術(shù)類閱讀的文章只有3篇文章，長(zhǎng)度從700詞到1500詞不等，要在限定的60分鐘內(nèi)完成閱讀并解答40道題，測(cè)試的重點(diǎn)是考查考生對(duì)文章基本結(jié)構(gòu)和一些重要信息的掌握情況。
寫(xiě)作
寫(xiě)作是測(cè)試語(yǔ)言能力的重要方式。目前大多數(shù)的國(guó)外院校要求申請(qǐng)者必須提供寫(xiě)作成績(jī)，而且將此作為錄取申請(qǐng)者的一項(xiàng)重要依據(jù)。
雅思考試普通培訓(xùn)類和學(xué)術(shù)類寫(xiě)作部分的試題有所不同，考試時(shí)間均為1小時(shí)，要求考生完成兩篇文章，第一篇字?jǐn)?shù)要求為150詞，第二篇字?jǐn)?shù)要求為250詞。普通培訓(xùn)類的第一道試題要求考生根據(jù)題目設(shè)定的情況寫(xiě)一封信，內(nèi)容多與日常生活有關(guān)。學(xué)術(shù)類的第一道題則要求考生在20分鐘內(nèi)對(duì)試卷提供的圖表所表達(dá)的信息、趨勢(shì)進(jìn)行準(zhǔn)確的描述。普通培訓(xùn)類和學(xué)術(shù)類的第二道題目風(fēng)格相同，都是要求考生就某一觀點(diǎn)或現(xiàn)象寫(xiě)一篇議論文。
口語(yǔ)
雅思考生面對(duì)的不是固定的考題，而是要直接面對(duì)考官，進(jìn)行一對(duì)一的面試。11-15分鐘考試。這也是雅思考試之所以得到越來(lái)越多的認(rèn)可的原因之一。
雅思的口語(yǔ)面試有一定的模式，評(píng)分具有公正度和可信度。口語(yǔ)部分有三個(gè)階段，第一階段，考官會(huì)提出一些簡(jiǎn)單的基本問(wèn)題，過(guò)渡到第二階段后，考官會(huì)給考生提供一張?jiān)掝}卡，由考生根據(jù)卡片上的話題展開(kāi)2-3分鐘的描述，考生有一分鐘時(shí)間做準(zhǔn)備，可以做筆記。在最后的一個(gè)階段，考官會(huì)請(qǐng)考生談?wù)撘粋€(gè)比較深入的話題，該話題同第二階段的話題有關(guān)。整個(gè)談話偏向生活化、口語(yǔ)化，較為輕松。
2.用于英國(guó)移民及簽證的雅思考試
考試用途及分類
自2015年4月起，英國(guó)簽證和移民局實(shí)施簽證類安全英語(yǔ)語(yǔ)言考試新政。用于英國(guó)簽證及移民的雅思考試是英國(guó)簽證和移民局對(duì)特定類型的英國(guó)簽證申請(qǐng)所開(kāi)設(shè)的考試。
考試結(jié)構(gòu)
學(xué)術(shù)類：聽(tīng)力：30分鐘+10分鐘 學(xué)術(shù)類閱讀：60分鐘 學(xué)術(shù)類寫(xiě)作：60分鐘 口語(yǔ)：11-14分鐘
培訓(xùn)類：聽(tīng)力：30分鐘+10分鐘 培訓(xùn)類閱讀：60分鐘 培訓(xùn)類寫(xiě)作：60分鐘 口語(yǔ)：11-14分鐘
考試形式
紙筆考試或機(jī)考+人人對(duì)話
3.雅思生活技能類考試
考試用途及分類
雅思考試生活技能類只測(cè)試考生的英語(yǔ)口語(yǔ)與聽(tīng)力水平，分為CEFR(歐洲語(yǔ)言共同參考框架)A1及B1級(jí)別兩類。該考試旨在滿足英國(guó)簽證與移民局對(duì)英國(guó)特定簽證申請(qǐng)的要求。
考試結(jié)構(gòu)
A1級(jí)別：適用于：配偶，探親類英國(guó)簽證申請(qǐng)
B1級(jí)別：適用于：入籍，永居類英國(guó)簽證申請(qǐng)
考試形式
人人對(duì)話
以上就是這幾個(gè)問(wèn)題讓你3分鐘了解雅思是什么的全部?jī)?nèi)容，在看了文章之后，大家應(yīng)該明白雅思考試有3個(gè)大類，我們常常說(shuō)的雅思考試其實(shí)是其中雅思考試這個(gè)大項(xiàng)中的學(xué)術(shù)類雅思考試。近期，雅思又在大陸考區(qū)增加了機(jī)考，這對(duì)于需要去的雅思成績(jī)的同學(xué)來(lái)說(shuō)，又多了一個(gè)選擇。
雅思閱讀全真練習(xí)系列：Sleep medication linked to bizarre behaviour
Sleep medication linked to bizarre behaviour
New evidence has linked a commonly prescribed sleep medication with bizarre behaviours, including a case in which a woman painted her front door in her sleep.
UK and Australian health agencies have released information about 240 cases of odd occurrences, including sleepwalking, amnesia and hallucinations among people taking the drug zolpidem.
While doctors say that zolpidem can offer much-needed relief for people with sleep disorders, they caution that these newly reported cases should prompt a closer look at its possible side effects.
Zolpidem, sold under the brand names Ambien, Stilnoct and Stilnox, is widely prescribed to treat insomnia and other disorders such as sleep apnea. Various forms of the drug, made by French pharmaceutical giant Sanofi-Aventis, were prescribed 674,500 times in 2005 in the UK.
A newly published report from Australia’s Federal Health Department describes 104 cases of hallucinations and 62 cases of amnesia experienced by people taking zolpidem since marketing of the drug began there in 2000. The health department report also mentioned 16 cases of strangesleepwalking by people taking the medication.
Midnight snack
In one of these sleepwalking cases a patient woke with a paintbrush in her hand after painting the front door to her house. Another case involved a woman who gained 23 kilograms over seven months while taking zolpidem. “It was only when she was discovered in front of an open refrigerator while asleep that the problem was resolved,” according to the report.
The UK’s Medicines and Healthcare products Regulatory Agency, meanwhile, has recorded 68 cases of adverse reactions to zolpidem from 2001 to 2005.
The newly reported cases in the UK and Australia add to a growing list of bizarre sleepwalking episodes linked to the drug in other countries, including reports of people sleep-driving while on the medication. In one case, a transatlantic flight had to be diverted after a passenger caused havoc after taking zolpidem.
Hypnotic effects
There is no biological pathway that has been proven to connect zolpidem with these behaviours. The drug is a benzodiazepine-like hypnotic that promotes deep sleep by interacting with brain receptors for a chemical called gamma-aminobutyric acid. While parts of the brain become less active during deep sleep, the body can still move, making sleepwalking a possibility.
The product information for prescribers advises that psychiatric adverse effects, including hallucinations, sleepwalking and nightmares, are more likely in the elderly, and treatment should be stopped if they occur.
Patient advocacy groups say they would like government health agencies and drug companies to take a closer look at the possible risks associated with sleep medicines. They stress that strange sleepwalking and sleep-driving behaviours can have risky consequences.
“When people do something in which they’re not in full control it’s always a danger,” says Vera Sharav of the New York-based Alliance for Human Research Protection, a US network that advocates responsible and ethical medical research practices.
Tried and tested
“The more reports that come out about the potential side effects of the drug, the more research needs to be done to understand if these are real side effects,” says sleep researcher Kenneth Wright at the University of Colorado in Boulder, US.
Millions of people have taken the drug without experiencing any strange side effects, points out Richard Millman at Brown Medical School, director of the Sleep Disorders Center of Lifespan Hospitals in Providence, Rhode Island, US. He says that unlike older types of sleep medications, zolpidem does not carry as great a risk of addiction.
And Wright notes that some of the reports of “sleep-driving” linked to zolpidem can be easily explained: some patients have wrongly taken the drug right before leaving work in hopes that the medicine will kick in by the time they reach home. Doctors stress that the medication should be taken just before going to bed.
The US Food & Drug Administration says it is continuing to "actively investigate" and collect information about cases linking zolpidem to unusual side effects.
The Ambien label currently lists strange behaviour as a “special concern” for people taking the drug. “It’s a possible rare adverse event,” says Sanofi-Aventis spokesperson Melissa Feltmann, adding that the strange sleepwalking behaviours “may not necessarily be caused by the drug” but instead result from an underlying disorder. She says that “the safety profile [of zolpidem] is well established”. The drug received approval in the US in 1993.
(721)
Questions 1-6 Do the following statements agree with the information given in the reading passage?
In boxes 1-6 on your answer sheet write
TRUE if the statement is true according to the passage
FALSE if the statement is false according to the passage
NOT GIVEN if the information is not given in the passage
1. Ambien, Stilnoct and Stilnox are brand names of one same drug treating insomnia.
2. The woman’s obesity problem wasn’t resolved until she stopped taking zolpidem.
3. Zolpidem received approval in the UK in 2001.
4. The bizarre behaviour of a passenger after taking zolpidem resulted in the diversion of a flight bound for the other side of the Atlantic.
5. Zolpidem is the only sleep medication that doesn’t cause addiction.
6. The sleep-driving occurrence resulted from the wrong use of zolpidem by an office worker.
Question 7-9 Choose the appropriate letters A-D and Write them in boxes 7-9 on your answer sheet.
7. How many cases of bizarre behaviours are described in an official report from Australia?
A. 68
B. 104
C. 182
D. 240
8. Which of the following is NOT mentioned in the product information about zolpidem?
A. Treatment should be stopped if side effects occur.
B. Medication should be taken just before going to bed.
C. Adverse effects are more likely in the elderly.
D. Side effects include nightmares, hallucinations and sleepwalking.
9. Who claimed that the safety description of zolpidem was well established?
A. Kenneth Wright
B. Melissa Feltmann
C. Richard Millman
D. Vera Sharav
Questions 10-13 Answer the following questions with NO MORE THAN THREE WORDS each in boxes 10-13.
10. How many times was French-made zolpidem prescribed in 2005 in Britain?
11. What kind of hypnotic is zolpidem as a drug which promotes deep sleep in patients?
12. What can sleepwalking and sleep-driving behaviours cause according to patient advocacy groups?
13. What US administration says that it has been investigating the cases relating zolpidem to unusual side effects?
